Drug Shortage Report for ALKERAN
| Report ID | 118933 |
| Drug Identification Number | 02087286 |
| Brand name | ALKERAN |
| Common or Proper name | Alkeran Injection / Melphalan |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | MELPHALAN BUFFER SOLUTION |
| Strength(s) | 50MG 10ML |
| Dosage form(s) | KIT POWDER FOR SOLUTION SOLUTION |
| Route of administration | INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 vial |
| ATC code | L01AA |
| ATC description | ALKYLATINGAGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2021-04-30 |
| Estimated end date | 2021-12-01 |
| Actual end date | 2021-11-04 |
| Shortage status | Resolved |
| Updated date | 2021-11-05 |
| Company comments | GR80016CA1 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2020-07-31 | French | Compare |
| v8 | 2020-07-31 | English | Compare |
| v7 | 2020-07-23 | English | Compare |
| v6 | 2020-07-22 | French | Compare |
| v5 | 2020-07-22 | English | Compare |
| v4 | 2020-07-22 | French | Compare |
| v3 | 2020-07-22 | English | Compare |
| v2 | 2020-06-25 | French | Compare |
| v1 | 2020-06-25 | English | Compare |